G.S. Avery
Impact in
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Gastroenterology top 1%
Papers in
- Pharmacology 35
- Inflammatory mediators and NSAID effects 14
- Antibiotics Pharmacokinetics and Efficacy 11
- Pharmacological Effects of Natural Compounds 6
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- T.M. SpeightRex N. BrogdenR.C. HeelR. M. PinderAndrea CarminePhyllis R. SawyerGary E. PakesRuth Pinder
- Journals
- Drugs (113 papers)Annals of Internal Medicine (1 paper)Virtual Defense Library (Ministerio de Defensa) (1 paper)Medical Entomology and Zoology (2 papers)
- Partner nations
- New ZealandAustralia
In The Last Decade
G.S. Avery
120 papers receiving 7.9k citations
Peers
Comparison fields: 5 of 159
- Pharmacology 1.6k
- Pharmacology 695
- Gastroenterology 317
- Pharmaceutical Science 350
- Cellular and Molecular Neuroscience 945
Countries citing papers authored by G.S. Avery
This map shows the geographic impact of G.S. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.S. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.S. Avery more than expected).
Fields of papers citing papers by G.S. Avery
This network shows the impact of papers produced by G.S. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.S. Avery. The network helps show where G.S. Avery may publish in the future.
Co-authorship network
The 22 scholars most cited alongside G.S. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Avery's drug treatment : a guide to the properties, choice, therapeutic use and economic value of drugs in disease management | 1997 | 3 |
| 2 | 1984 | 90 | |
| 3 | 1983 | 86 | |
| 4 | 1982 | 5 | |
| 5 | 1982 | 40 | |
| 6 | 1980 | 15 | |
| 7 | 1979 | 28 | |
| 8 | 1979 | 84 | |
| 9 | 1979 | 2 | |
| 10 | 1978 | 76 | |
| 11 | 1978 | 244 | |
| 12 | 1978 | 117 | |
| 13 | 1978 | 88 | |
| 14 | 1977 | 81 | |
| 15 | 1977 | 103 | |
| 16 | 1976 | 264 | |
| 17 | 1975 | 71 | |
| 18 | 1974 | 94 | |
| 19 | 1974 | 5 | |
| 20 | 1974 | 1 |
About G.S. Avery
G.S. Avery is a scholar working on Pharmacology, Molecular Medicine, Pharmacology, Immunology and Allergy and Gastroenterology, having authored 122 papers that have together received 8.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Asthma and respiratory diseases (9 papers), Antibiotic Resistance in Bacteria (7 papers), Allergic Rhinitis and Sensitization (6 papers), Pharmacological Effects of Natural Compounds (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Respiratory and Cough-Related Research (6 papers). The work is most often cited by research in Pharmacology (1.6k citations), Pharmacology (695 citations), Gastroenterology (317 citations), Pharmaceutical Science (350 citations) and Cellular and Molecular Neuroscience (945 citations). G.S. Avery has collaborated with scholars based in New Zealand and Australia. Frequent co-authors include T.M. Speight, Rex N. Brogden, R.C. Heel, R. M. Pinder, Andrea Carmine, Phyllis R. Sawyer, Gary E. Pakes, Ruth Pinder, Paul Morley and David M. Richards. Their work appears in journals such as Drugs, Annals of Internal Medicine, Virtual Defense Library (Ministerio de Defensa) and Medical Entomology and Zoology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.